Navigation Links
22 of America's Most Promising Scientists Selected as 2011 Pew Scholars in the Biomedical Sciences
Date:6/13/2011

PHILADELPHIA, June 14, 2011 /PRNewswire-USNewswire/ -- Twenty-two of America's most promising scientists have been named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts.  The 2011 Pew Scholars will join a select community that includes MacArthur Fellows, recipients of the Albert Lasker Medical Research Award and three Nobel Prize winners.  Research by the new class of Scholars is related to many human diseases ranging from Alzheimer's to diabetes to ocular degeneration. The program encourages early-career scientists to advance research that leads to important medical breakthroughs and treatments.

"Pew is pleased to provide this country's most ambitious and dedicated scientists with timely funding that enables them to explore novel areas of investigation early in their careers, at what may be the most inventive and creative period in their research," said Rebecca W. Rimel, president and CEO of The Pew Charitable Trusts.

CLICK HERE TO SEE A VIDEO SHOWCASING THE WORK OF THE BIOMEDICAL SCHOLARS

To date, the program has invested more than $125 million to fund over 500 scholars. It is a rigorously competitive program where recipients receive $240,000 over four years to pursue their research without restriction. Applicants who work in all areas of physical and life sciences related to biomedical study must be nominated by an invited institution and demonstrate both excellence and innovation in their research. This year, 175 institutions were requested to nominate a candidate and 136 eligible nominations were received.

"Early recognition of young scientists with ideas that challenge their fields is essential for the vitality of the biomedical sciences," said Craig C. Mello, Ph.D., a 1995 Pew Scholar, a 2006 Nobel Laureate in Physiology or Medicine and the chair of the national advisory committee for the program. "From my own experience as a Pew Scholar and member of the advisory board, this program gives young scientists the confidence to pursue risky projects, and to push the boundaries of their fields, planting the seeds for major scientific advancements.  I welcome these promising scientists into the Pew Biomedical Scholars family and look forward to watching as their research unfolds in the years ahead."

The new 2011 Pew Scholars are:


  • Christine M. Dunham, Ph.D.

  • Emory University School of Medicine Structural Biology and Pathogenesis


  • Thomas G. Fazzio, Ph.D.

  • University of Massachusetts Medical SchoolStem Cell Biology


  • Max L. Fletcher, Ph.D.

  • University of Tennessee Health Science CenterNeuroscience


  • Hunter B. Fraser, Ph.D.

  • Stanford UniversityGene Regulation


  • Melissa K. Gardner, Ph.D.

  • University of MinnesotaCell Biology and Biophysics


  • Mary Gehring, Ph.D.

  • Whitehead Institute for Biomedical ResearchGene Regulation and Epigenetics


  • Jeff Gore, Ph.D.

  • Massachusetts Institute of TechnologyBiophysics and Systems Biology


  • Takaki Komiyama, Ph.D.

  • University of California, San DiegoNeuroscience


  • Mei Kong, Ph.D.

  • Beckman Institute, City of Hope Cancer Cell Biology


  • Michael S. Kuhns, Ph.D.

  • University of ArizonaImmunology


  • Erica Larschan, Ph.D.

  • Brown UniversityEpigenetics


  • Eros Lazzerini Denchi, Ph.D.

  • Scripps Research InstituteAging and Stem Cell Biology


  • Ann C. Morris, Ph.D.

  • University of KentuckyDevelopmental Neurobiology and Genetics


  • James B. Moseley, Ph.D.

  • Dartmouth Medical SchoolCell Biology


  • Suzanne M. Nobel, M.D., Ph.D.

  • University of California, San FranciscoFungal Pathogenesis


  • Brad J. Nolen, Ph.D.

  • University of OregonStructural Biology


  • Chad G. Pearson, Ph.D.

  • University of Colorado, DenverCell Biology


  • Sharad Ramanathan, Ph.D.

  • Harvard University Neuroscience and Systems Biology


  • Anthony R. Richardson, Ph.D.

  • University of North Carolina at Chapel HillMicrobiology and Immunology


  • Niels Ringstad, Ph.D.

  • New York University School of MedicineNeuroscience


  • Georgios Skiniotis, Ph.D.

  • University of MichiganStructural Biology and Membrane Biology


  • Liang Zhou, M.D., Ph.D.

  • Northwestern UniversityImmunology and Gene RegulationFor full biographies and information regarding the scholars' research, please visit www.pewscholars.org.

    The Pew Charitable Trusts (www.pewtrusts.org) is driven by the power of knowledge to solve today's most challenging problems. Pew applies a rigorous, analytical approach to improve public policy, inform the public and stimulate civic life. We partner with a diverse range of donors, public and private organizations and concerned citizens who share our commitment to fact-based solutions and goal-driven investments to improve society.


    '/>"/>
    SOURCE The Pew Charitable Trusts
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Terumo Americas Holding, Inc., Agrees to Acquire Harvest Technologies Corporation, a Leader in the Development of Point-of-Care Cellular Therapy
    2. iLife Americas, LLC Enters U.S. Wellness and Therapeutic Markets
    3. Americas on the Waterway Supports US Oncology Foundation
    4. Cochlear Americas Provides Support for Cochlear Implant Recipients to Pursue Higher Education
    5. Abbott to Present at UBS Best of Americas Investment Conference
    6. Jennerex and Partners Present Positive JX-594 Randomized Phase 2 Clinical Data Showing Promising Survival Benefit in Patients with Advanced Liver Cancer
    7. Ontario Institute for Cancer Research Announces Spin Off Companies Developing Promising Anticancer Technologies
    8. Reportlinker Adds Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients
    9. Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B
    10. New findings promising for transformation optics, cloaking
    11. New hydrolysis model promising tool in cellulosic biofuel studies
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/8/2016)... 8, 2016 Oxford Gene Technology ... SureSeq™ NGS panel range with the launch of the SureSeq ... study of variants in familial hypercholesterolemia (FH). The panel delivers ... on a single small panel and allows customisation by ,mix ... all exons for LDLR , P C ...
    (Date:12/8/2016)... ... December 08, 2016 , ... Microbial genomics leader, ... uBiome is one of just six company finalists in the Health & Medicine ... uBiome, companies nominated as finalists in this year’s awards include Google, SpaceX, Oculus, ...
    (Date:12/8/2016)... 8, 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), ... and plans to commercialize innovative therapeutics for patients ... stock were approved for trading on the OTCQX ... the OTCQX, effective today, under the ticker symbol ... market, companies must meet high financial standards, follow ...
    (Date:12/8/2016)... 8, 2016   Biocept, Inc . (NASDAQ: ... of clinically actionable liquid biopsy tests to improve ... data featuring its Target Selector™ Circulating Tumor Cell ... the detection of actionable biomarkers in patients with ... by Sara Cannon Research Institute (SCRI), the research ...
    Breaking Biology Technology:
    (Date:12/5/2016)... -- The Office of Justice Programs, National Institute of ... or Replace Medico Legal Autopsies?" on NIJ.gov.  The ... forensic autopsies with postmortem X-ray computed tomography, commonly ... to recommendations made by The National Academy of ... a potential component of medicolegal death investigations. NIJ,s ...
    (Date:12/2/2016)... 2016   SoftServe , a global digital ... an electrocardiogram (ECG) biosensor analysis system for continuous ... asset. The smart system ensures device-to-device communication between ... and mobile devices to easily ,recognize, and monitor ... vehicle technology advances, so too must the security ...
    (Date:11/30/2016)... , Nov. 30, 2016  higi SH llc ... partnership initiative targeting national brands, industry thought-leaders and ... their respective audiences for taking steps to live ... inception in 2012, higi has built the largest ... over 38 million people who have conducted over ...
    Breaking Biology News(10 mins):